United Kingdom Diabetes Device Market Report by Types, Distribution Channel, Cities and Companies Analysis 2026-2034

The United Kingdom diabetes devices market is expected to grow from US$ 1.21 billion in 2025 to US$ 2.33 billion by 2034, registering a compound annual growth rate (CAGR) of 7.53% from 2026 to 2034. This is due to the rising incidence of diabetes, a growing demand for continuous glucose monitors, insulin delivery devices, as well as a focus on early diagnosis, treatment, and management of diabetes by the healthcare sector in the UK.

United Kingdom Diabetes Device Market Outlook

Devices for diabetes care are medical devices used to aid diabetic patients to track blood glucose levels as well as administer insulin or treatment to control diabetes. Examples of devices for diabetes care include SMBG meters, continuous glucose monitoring systems, insulin pens, insulin pumps, as well as digital platforms used to track blood glucose readings. By allowing diabetic individuals to monitor their blood glucose levels regularly as well as deliver accurate insulin amounts via devices, improving blood glucose level stability as well as overall diabetic control is possible. Additionally, there is an increasing emphasis on digital connectivity with devices for diabetes management.

In the United Kingdom, diabetes products are gaining much acceptance, particularly as a result of the rising number of patients suffering from both type 1 and 2 diabetes. The UK healthcare system emphasizes early diagnosis, prevention, and self-management, factors contributing to the increased adoption of glucose monitoring and insulin delivery devices. Increased accessibility, integration, and awareness of CGM technology, as well as advancements within the field, have helped promote the acceptance of diabetes products within the UK.

Growth Driver in the UK Market for Diabetes Devices

Increasing Rates of Diabetes and Aging Population

The rising number of diabetic cases in the United Kingdom is also propelling the growth of the diabetes devices market in this region. The number of type 1 and type 2 diabetes cases is rising steadily due to lifestyle changes, obesity, and an increased lifespan. The rising geriatric population also drives the demand for diabetes management, as older patients have to constantly test their glucose levels and insulin intake. The role of diabetes devices in managing this condition is profound; it helps to prevent complications and minimize hospitalizations for these patients. This drives steady demand for SMBG devices, continuous glucose management systems, and insulin delivery systems due to an increasing patient base in this region. According to The British Diabetic Association, "Diabetes prevalence 2021," it has been observed that there has been an upswing in the number of patients being diagnosed with diabetes in the UK by an amount over 150,000 since last year’s statistics in 2020. The number of people considered to have an increased risk of being diagnosed with type 2 diabetes in the UK is over 13.6 million. The number of people in the UK diagnosed and undiagnosed is also projected to reach 5.5 million by 2030.

Deployment of Advanced Monitoring & Digital Health Solutions

Technological advancements are also a major contributing factor to the development of the diabetes devices market in the UK. Continuous glucose monitoring devices, glucose pens, and insulin-delivery devices that automatically deliver doses of insulin with precise measures in mind continue to become popular as they help to improve control of glucose levels in a more convenient manner and provide real-time data to support effective decision-making. In addition to this, technological devices improve patient compliance with medication and health recommendations compared to traditional devices that monitor glucose levels in a more manual manner. As a result of this significant development in digital health, use of connected devices for diabetes continues to gain popularity in the UK. May 2023: The National Institute for Clinical Excellence (NICE) took a crucial step to further improve healthcare in the country by updating recommendations to use CGMs and flash glucose monitoring in children with type 2 diabetes. This is a great step in the right direction for the entire United Kingdom because now they will not have to use finger pricking to monitor blood glucose levels in children. Finger pricking has been a great development in the past but now poses serious stress to children and parents in particular because they require a very high number to be obtained daily.

Emphasis on Preventive and Managed Care

The UK healthcare system is very focused on the preventive care and self-management of people suffering from chronic diseases. Diabetes care devices help patients test their blood sugar levels on a regular basis and then take the correct decisions regarding diet, exercise, and medicines. Educational initiatives and medical advice promote the use of diabetes monitoring devices to keep sugar levels under control. The self-management approach in diabetes care is on the rise; therefore, the market for Diabetes devices is also increasing. In November 2023, Medtronic plc. Launched the highly advanced hybrid closed-loop insulin pump system.

Challenge in United Kingdom Diabetes Device Market

Budgetary Restraints and the Reimbursement

Among the major challenges in the UK diabetes devices market is cost constraints in the healthcare setting. This is because innovative devices such as CGM devices and insulin pumps have higher costs. This may limit access to these innovative devices despite their established benefits. Cost-effectiveness analysis is important in determining access to devices. This results in challenges for devices that have higher costs.

Patient Adoption Issues, Device Usability Challenges

Although diabetes care devices are more widely available, not all patients easily embrace the devices. This is due to the challenges posed by the usability of the devices. This is where some people find the devices uncomfortable, complex, and intrusive. The elderly or people lacking experience with devices may not easily understand the operation of the devices.

United Kingdom SMBG Device Market

The self-monitoring of blood glucose (SMBG) devices market in the UK represents an established sector of the diabetes care landscape. SMBG devices such as glucose meters and strips have become widely accepted among patients with either type 1 or type 2 diabetes. The devices are still widely needed among insulin-consuming patients as well as those that have controlled their diabetes through lifestyle modifications and oral therapy. The cost-effectiveness, simplicity, and user-friendliness of these devices have ensured that they continue to find favor, especially among the elderly. While the rate of growth may be sluggish in comparison to other innovative devices, there is still steady demand that ensures the stability of the UK SMBG devices market. The SMBG devices have become integral in diagnosis and short-term management of the disease; therefore, their need within the UK diabetes management context cannot be overemphasized.

United Kingdom CGM Devices Market

“The market for continuous glucose monitors in the UK is growing because of the need for real-time diabetes control. Continuous glucose monitors offer the benefits of continuous glucose values, trend data, and alarm notifications, enabling patients to control blood sugar more effectively without needing to check blood through finger sticking. Continuous glucose monitors are primarily used by those with type 1 diabetes or insulin-requiring patients with type 2 diabetes. Integration with smartphones increases user friendliness and engagement for patients. With increased acceptance and emphasis on long-term clinical outcomes, use of continuous glucose monitors is also expected to increase in the UK,” says a report. Technologies such as CGM are becoming the cornerstone of managing diabetes in the UK.

United Kingdom Insulin Pumps Device Market

The market for the insulin pumps device in the United Kingdom is fueled by the demand for accurate and flexible insulin infusion systems. Insulin pump devices enable continuous subcutaneous insulin infusion, which is more flexible compared to multiple injections in a day. These machines are largely preferred for type 1 diabetes sufferers and those with intensive insulinotherapy. With recent innovations in these devices, such as the ability to automate insulin infusion, the safety and efficacy level of treatment has been significantly improved. Though these machines pose some expense constraints in terms of usage, the market still constitutes a highly rewarding segment due to medical requirements and patient demand for better treatments.

United Kingdom Insulin Pen Device Market

Insulin pens have gained huge acceptance in the UK due to their convenience, portability, and accuracy of dosage. Insulin pens have been found more convenient in insulin dosages when compared with syringes. Insulin pens are also prescribed in cases of both new and long-standing diabetics. Insulin pens can be both disposable and reusable based on the convenience of the diabetic. Incremental innovation in terms of smart insulin pens with the functionality of tracking the dosage has increased their convenience. Persistent preferences of physicians and diabetics have helped propel the market of insulin pens in the UK.

United Kingdom Diabetes Device Diagnostics Centers Market

The UK diabetes devices market faces challenges from the growing competition in the SMBG devices sector. This is a result of increasing awareness of the demand for diabetes devices among people with diabetes. Several vendors for these devices have entered the global market. This competition has further led to the development of advanced SMBG devices. The increasing competition in the diabetes devices sector has posed a challenge for the growth of the UK diabetes devices market. The competition in the SMBG devices sector has increased the demand for quality devices.

United Kingdom Diabetes Device Retail Pharmacies Market

Retail pharmacies are one of the key distribution channels for diabetes devices in the UK. Pharmacies serve as a point of access for patients to get their hands on glucose meters, test strips, insulin pens, CGM sensors, and other diabetes devices and accessories. With the ever-increasing prevalence of diabetes, the retail pharmacies have emerged as key points of access for patients to get associated with diabetes devices and management in the UK. Pharmacists are also associated with educating and helping patients in the use of devices, thus improving compliance rates.

London Diabetes Device Market

London is the largest and most developed diabetes devices market in the United Kingdom. The large population density, prevalence of diabetes, and good accessibility to top-notch medical hospitals and clinics contribute to the large market for diabetes devices such as glucose monitors and insulin pumps in the region. London is at the forefront regarding medical innovation and digital healthcare adoption, leading to the speedy adoption of continuous glucose monitors, insulin pumps, and smart insulin pens. Also, the population is generally well-aware and benefits from the specialized care and early adoption of innovative medical devices. Moreover, the easy accessibility to retail pharmacies and diagnostic centers makes diabetes devices more accessible. Moreover, the region is also focused on the concept and practice of preventive healthcare and chronic care, thereby facilitating regular use of diabetes devices.

Manchester Diabetes Device Market

The Manchester diabetic device market is fueled by the increasing number of diabetic patients and the developing health infrastructure in the Greater Manchester area. Diabetic care is a core area of focus in the Manchester area, which is a positive contributing factor to the increased use of SMBG devices, insulin pens, and now a rising trend of CGM devices. Hospital and community-based healthcare facilities help promote early detection and remote monitoring of diabetic patients through the use of devices. Cost-effective and simple-to-use devices are widely preferable, mainly among type 2 diabetic patients. Retail pharmacies act as a major distribution channel that provides continuous access to diabetic monitoring devices and supplies. Accordingly, increased knowledge of advanced diabetic care practices is a significant trigger that fuels the rising use of digital devices.

Leeds Diabetes Device Market

The UK diabetes devices market in Leeds is significant owing to its robust presence in the region’s healthcare system and a focus on preventive healthcare. The number of people in Leeds is catered to by diabetes devices for monitoring, and insulin pens are in popular demand, while there is a slow but rising trend for CGM devices through specialty care. The diabetes devices market in Leeds has access to a strongly integrated healthcare system that pushes for patient awareness and self-management for diabetes. Along with a focus on chronic disease management, there is a stable growth in diabetes devices, especially for a product that provides a correct blend of affordability, durability, and clinical success.

Liverpool Diabetes Device Market

The diabetes device market in Liverpool is driven by effective public healthcare services and a focus on managing the prevalence of chronic diseases. The incidence of diabetes is reasonably high within Liverpool, which boosts the demand for glucose testing and insulin delivery systems. The practice of SMBG has been prevalent due to its cost-effectiveness and accessibility, while knowledge about CGM systems is increasingly being developed. The public healthcare system and hospitals within Liverpool are focused on continuous patient monitoring and education, which helps to ensure continuous use of the diabetes devices. The city's focus on preventative healthcare and disease management helps to ensure a continued demand for diabetes devices, making it a significant local market in the UK.

Market Segmentations

Types- Industry is divided into 4 viewpoints:

• Self-Monitoring Devices
• Continuous Glucose-Monitoring Devices
• Insulin Pumps
• Insulin Pens

Distribution Channel - Industry is divided into 4 viewpoints:

• Hospital Pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies

Top Cities

• London
• Manchester
• Birmingham
• Leeds
• Liverpool
• Edinburgh
• Glasgow
• Tyneside
• Bristol
• Rest of United Kingdom

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments & Strategies
• Product Portfolio & Product Launch in Last 1 Year
• Revenue

Company Analysis

• Abbott Laboratories
• Roche
• Medtronic
• Novo Nordisk A/S
• Terumo Corporation
• Eli Lilly
• BD
• Dexcom Inc